Company
Collegium Pharmaceutical
Healthier people. Stronger communities.
Also known as Collegium Pharmaceutical, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Collegium Pharmaceutical, Inc.
- collegiumpharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Collegium Pharmaceutical is a dynamic biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system (CNS) and pain conditions.
Funding snapshot
- Total raised
- $97.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $20M2018-11-08
Funding rounds
- Round, 2018
- $20M2018-11-08, SEC form D sold, 1 investor
- Round, 2015
- $50M2015-03-06, SEC form D sold, 18 investors
- Round, 2013
- $4M2013-08-27, SEC form D sold, 13 investors
- Round, 2012
- $22.5M2012-02-10, SEC form D sold, 12 investors
- Round, 2010
- $1M2010-03-01, SEC form D sold, 7 investors
Loading relationship preview